Comparative Safety Analysis of Opioid Agonist Treatment in Pregnant Women with Opioid Use Disorder: A Population-Based Study.

Shuang WangKimford J MeadorJayne PawasauskasAdam K LewkowitzKristina E WardTodd N BrothersAbraham HartzemaBrian J QuilliamXuerong Wen

Published in: Drug safety (2023)

Methadone and buprenorphine prescribed for the treatment of opioid use disorder during pregnancy are associated with varying perinatal risks. However, buprenorphine may be preferred in the setting of pregnancy opioid agonist treatment. Further research is necessary to confirm our findings and minimize residual confounding.

Keyphrases

pregnant women
chronic pain
risk assessment
preterm birth
smoking cessation